Titan Pharma (TTNP) Tops Q1 EPS by 1c

Titan Pharma (NASDAQ: TTNP) reported Q1 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13). Revenue for the quarter came in at $1.1 million versus the consensus estimate of $70 thousand.

For earnings history and earnings-related data on Titan Pharma (TTNP) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
• Boxlight Corporation (BOXL) Tops Q2 EPS by 2050c